|
|
|
|
Forensic Laboratories Develops First Oral Fluid Test For Tapentadol
Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain management.Previously, laboratories...
|
|
|
3/15/10 - Forensic Laboratories Develops First Oral Fluid Test for Tapentadol
DENVER, March 15 /PRNewswire/ Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain...
|
|
|
Forensic Laboratories Develops First Oral Fluid Test for Tapentadol
DENVER, March 15 /PRNewswire/ Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain...
|
|
|
Forensic Laboratories introduces first oral fluid test for Tapentadol
Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain management.Previously, laboratories...
|
|
|
Department Of Health And Children Statement In Relation To Legislation To Be Made Under Misuse Of Drugs Act 19
to the commencement of a notification process under Directive 98/34/EC (the 'Technical Standards' Directive) as amended by Directive 98/48/EC of the Government's intention to make a Declaration Order under the Misuse of Drugs Act 1977 declaring certain...
|
|
|
Summer Street Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy
Summer Street initiates coverage on NPS Pharmaceuticals (Nasdaq: NPSP) with a Buy rating and $11 price target.Summer analyst says, "Over the coming years, NPS will transform itself from a royalty play to a company with a commercial presence in orphan...
|
|
|
Lower Back Pain Therapy: Data on lower back pain therapy described by researchers at Johnson & Johnson
Today's Medical & Research News Data on described by researchers at Johnson & Johnson March 2nd, 2010 Printer-Friendly Version City:Titusville State:NJ Country:United States Analgesia Drug Development Drugs Neurology Opioid Receptors Pain Medicine...
|
|
|
Pharmacokinetics: New pharmacokinetics study results reported from Johnson & Johnson
Today's Medical & Research News Pharmacokinetics New pharmacokinetics study results reported from Johnson & Johnson February 26th, 2010 Printer-Friendly Version Country:Belgium Acetaminophen Analgesia Clinical Research Drug Development Drugs Naproxen...
|
|
|
Tapentadol Extended Release Data to Be Presented at American Academy of Pain Medicine Annual Meeting
SAN ANTONIO, Feb.4 /PRNewswire/ -- Data from three important studies on tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older, will be...
|
|
|
J&J's net declines by 5.3% to $12.3 billion during 2009
Johnson & Johnson (J&J) has suffered setback during the year ended December 2009 on account of litigation matters and lower sales.The company's net earnings declined by 5.3 per cent to US$12,266 million from $12,949 million in the previous year.
|
